rspНаучно-практическая ревматологияRheumatology Science and Practice1995-44841995-4492IMA-PRESS, LLC10.47360/1995-4484-2021-255-262rsp-3035Research ArticleПРОБЛЕМЫ РЕВМАТОЛОГИИ В ПЕРИОД ПАНДЕМИИ КОРОНОВИРУСНОЙ БОЛЕЗНИ 2019PROBLEMS OF RHEUMATOLOGY DURING THE 2019 CORONAVIRUS PANDEMIC«Постковидный синдром»: в центре внимания скелетно-мышечная боль“Post-COVID syndrome”: The focus is on musculoskeletal painhttps://orcid.org/0000-0002-1391-0711КаратеевА. Е.KarateevA. E.

115522, Москва, Каширское шоссе, 34а

115522, Moscow, Kashirskoye Highway, 34A 

https://orcid.org/0000-0001-5382-6357АмирджановаВ. Н.AmirdzhanovaV. N.

115522, Москва, Каширское шоссе, 34а

115522, Moscow, Kashirskoye Highway, 34A 

https://orcid.org/0000-0002-1598-8360НасоновЕ. Л.NasonovE. L.

115522, Москва, Каширское шоссе, 34а; 119991, Москва, ул. Трубецкая, 8, стр. 2

115522, Moscow, Kashirskoye Highway, 34A; 119991, Moscow, Trubetskaya str., 8, building 2

https://orcid.org/0000-0002-6068-3080ЛилаА. М.LilaA. M.

115522, Москва, Каширское шоссе, 34а; 125993, Москва, ул. Баррикадная, 2/1, стр. 1

115522, Moscow, Kashirskoye Highway, 34A; 125993, Moscow, Barrikadnaya str., 2/1, building 1

https://orcid.org/0000-0001-7017-0898АлексееваЛ. И.AlekseevaL. I.

115522, Москва, Каширское шоссе, 34а

115522, Moscow, Kashirskoye Highway, 34A 

https://orcid.org/0000-0001-5103-5447ПогожеваЕ. Ю.PogozhevaE. Yu.

115522, Москва, Каширское шоссе, 34а

115522, Moscow, Kashirskoye Highway, 34A 

https://orcid.org/0000-0002-2475-8620ФилатоваЕ. С.FilatovaE. S.

115522, Москва, Каширское шоссе, 34а

115522, Moscow, Kashirskoye Highway, 34A 

https://orcid.org/0000-0002-7179-8174НестеренкоВ. А.NesterenkoV. A.

115522, Москва, Каширское шоссе, 34а

115522, Moscow, Kashirskoye Highway, 34A 

ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»РоссияV.A. Nasonova Research Institute of RheumatologyRussian FederationФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»; ФГАОУ ВО «Первый Московский государственный медицинский университет имени И.М. Сеченова» Минздрава России (Сеченовский Университет)РоссияV.A. Nasonova Research Institute of Rheumatology; I.M. Sechenov First Moscow State Medical University of the Ministry of Health Care of Russian Federation (Sechenov University)Russian FederationФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»; ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава РоссииРоссияV.A. Nasonova Research Institute of Rheumatology; Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian FederationRussian Federation202113072021593255262Copyright © Каратеев А.Е., Амирджанова В.Н., Насонов Е.Л., Лила А.М., Алексеева Л.И., Погожева Е.Ю., Филатова Е.С., Нестеренко В.А., 20212021Каратеев А.Е., Амирджанова В.Н., Насонов Е.Л., Лила А.М., Алексеева Л.И., Погожева Е.Ю., Филатова Е.С., Нестеренко В.А.Karateev A.E., Amirdzhanova V.N., Nasonov E.L., Lila A.M., Alekseeva L.I., Pogozheva E.Y., Filatova E.S., Nesterenko V.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://rsp.mediar-press.net/rsp/article/view/3035

Борьба с последствиями COVID-19 – заболевания, вызванного новой коронавирусной инфекцией SARSCoV-2, – является серьезной и весьма актуальной задачей, стоящей перед современной медициной. COVID19 нередко имеет тяжелое течение и сопровождается полиорганным поражением, системным иммунным воспалением, коагулопатией, нейроэндокринными и метаболическими нарушениями. Даже при относительно благоприятном течении последствиями инфекции SARS-CoV-2 могут стать дегенеративные изменения многих органов (легочный фиброз, кардиосклероз), различные функциональные и психоэмоциональные расстройства. Вследствие этого у 10–50% пациентов в течение длительного времени после стихания острых проявлений COVID-19 и элиминации вируса сохраняются различные неприятные симптомы. Данная патология обозначается как «постковидный синдром» (ПКС). Основными элементами ПКС являются хроническая боль, утомляемость и психоэмоциональные проблемы. Функциональные нарушения, аутоиммунные процессы и тяжелый психологический дистресс после перенесенного COVID-19 могут вызывать развитие и обострение заболеваний, характеризующихся хронической болью и утомляемостью, таких как фибромиалгия и синдром хронической усталости. Терапия и профилактика ПКС включают коррекцию функциональных нарушений, контроль боли, последовательную физическую, психологическую и социальную реабилитацию. 

Combating the consequences of COVID-19, a disease caused by the new coronavirus infection SARS-CoV-2, is a serious and very urgent task facing modern medicine. COVID-19 often has a severe course and is accompanied by multiple organ damage, systemic immune inflammation, coagulopathy, neuroendocrine and metabolic disorders. Even with a relatively favorable course, the consequences of SARS-CoV-2 infection can be degenerative changes in many organs (pulmonary fibrosis, cardiosclerosis), various functional and psychoemotional disorders. As a result, in 10–50% of patients, various unpleasant symptoms persist for a long time after the acute manifestations of COVID-19 subside and the virus is eliminated. This pathology is referred to as “post-COVID syndrome” (PCS). The main elements of PCS are chronic pain, fatigue, and psychoemotional problems. Functional disorders, autoimmune processes, and severe psychological distress after COVID-19 can cause the development and exacerbation of diseases characterized by chronic pain and fatigue, such as fibromyalgia and chronic fatigue syndrome. Therapy and prevention of PCS include correction of functional disorders, pain control, and consistent physical, psychological, and social rehabilitation.

COVID-19постковидный синдромскелетно-мышечная больCOVID-19post-COVID syndromemusculoskeletal painReferencesНасонов ЕЛ. Коронавирусная болезнь 2019 (COVID-19): размышления ревматолога. Научно-практическая ревматология. 2020;58(2):123-132. doi: 10.14412/1995-4484-2020-123-132Nasonov EL. Coronavirus disease 2019 (COVID-19): Reflections of a rheumatologist. NauchcnoPrakticheskaya Revmatologia = Rheumatology Science and Practice. 2020;58(2):123-132 (In Russ.). doi: 10.14412/1995-4484-2020-123-132Spreeuwenberg P, Kroneman M, Paget J. Reassessing the global mortality burden of the 1918 influenza pandemic. Am J Epidemiol. 2018;187(12):2561-2567. doi: 10.1093/aje/kwy191Spreeuwenberg P, Kroneman M, Paget J. Reassessing the global mortality burden of the 1918 influenza pandemic. Am J Epidemiol. 2018;187(12):2561-2567. doi: 10.1093/aje/kwy191COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). URL: https://origin-coronavirus.jhu.edu/map.html. (Accessed: 18th April 2021) .COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). URL: https://origin-coronavirus.jhu.edu/map.html. (Accessed: 18th April 2021) .Darif D, Hammi I, Kihel A, El Idrissi Saik I, Guessous F, Akarid K. The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong? Microb Pathog. 2021;18(153):104799. doi: 10.1016/j.micpath.2021.104799Darif D, Hammi I, Kihel A, El Idrissi Saik I, Guessous F, Akarid K. The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong? Microb Pathog. 2021;18(153):104799. doi: 10.1016/j.micpath.2021.104799Capaccione KM, Yang H, West E, Patel H, Ma H, Patel S, et al. Pathophysiology and imaging findings of COVID-19 infection: An organ-system based review. Acad Radiol. 2021;28(5):595-607. doi: 10.1016/j.acra.2021.01.022Capaccione KM, Yang H, West E, Patel H, Ma H, Patel S, et al. Pathophysiology and imaging findings of COVID-19 infection: An organ-system based review. Acad Radiol. 2021;28(5):595-607. doi: 10.1016/j.acra.2021.01.022Oronsky B, Larson C, Hammond TC, Oronsky A, Kesari S, Lybeck M, et al. A review of persistent post-COVID syndrome (PPCS). Clin Rev Allergy Immunol. 2021;20:1-9. doi: 10.1007/s12016-021-08848-3Oronsky B, Larson C, Hammond TC, Oronsky A, Kesari S, Lybeck M, et al. A review of persistent post-COVID syndrome (PPCS). Clin Rev Allergy Immunol. 2021;20:1-9. doi: 10.1007/s12016-021-08848-3Summary of ICD coding for COVID-19. URL: http://www.whofic.org.za/SummaryICDcoding.pdf (Accessed: 18 April 2021).Summary of ICD coding for COVID-19. URL: http://www.whofic.org.za/SummaryICDcoding.pdf (Accessed: 18 April 2021).McDonald LT. Healing after COVID-19: are survivors at risk for pulmonary fibrosis? Am J Physiol Lung Cell Mol Physiol. 2021;320(2):L257-L265. doi: 10.1152/ajplung.00238.2020McDonald LT. Healing after COVID-19: are survivors at risk for pulmonary fibrosis? Am J Physiol Lung Cell Mol Physiol. 2021;320(2):L257-L265. doi: 10.1152/ajplung.00238.2020Zhang C, Wu Z, Li JW, Tan K, Yang W, Zhao H, et al. Discharge may not be the end of treatment: Pay attention to pulmonary fibrosis caused by severe COVID-19. J Med Virol. 2021;93(3):1378-1386. doi: 10.1002/jmv.26634Zhang C, Wu Z, Li JW, Tan K, Yang W, Zhao H, et al. Discharge may not be the end of treatment: Pay attention to pulmonary fibrosis caused by severe COVID-19. J Med Virol. 2021;93(3):1378-1386. doi: 10.1002/jmv.26634Budi EH, Schaub JR, Decaris M, Turner S, Derynck R. TGF-beta as a driver of fibrosis: Physiological roles and therapeutic opportunities. J Pathol. 2021;254(62). doi: 10.1002/path.5680Budi EH, Schaub JR, Decaris M, Turner S, Derynck R. TGF-beta as a driver of fibrosis: Physiological roles and therapeutic opportunities. J Pathol. 2021;254(62). doi: 10.1002/path.5680Shchendrygina A, Nagel E, Puntmann VO, Valbuena-Lopez S. COVID-19 myocarditis and prospective heart failure burden. Expert Rev Cardiovasc Ther. 2021;19(1):5-14. doi: 10.1080/14779072.2021.1844005Shchendrygina A, Nagel E, Puntmann VO, Valbuena-Lopez S. COVID-19 myocarditis and prospective heart failure burden. Expert Rev Cardiovasc Ther. 2021;19(1):5-14. doi: 10.1080/14779072.2021.1844005Ferrara F, Vitiello A. Scientific and pharmacological rationale for the treatment of cardiac damage caused by COVID-19. Discov Med. 2020;30(161):155-161.Ferrara F, Vitiello A. Scientific and pharmacological rationale for the treatment of cardiac damage caused by COVID-19. Discov Med. 2020;30(161):155-161.Di Minno A, Ambrosino P, Calcaterra I, Di Minno MND. COVID-19 and venous thromboembolism: A meta-analysis of literature studies. Semin Thromb Hemost. 2020;46(7):763-771. doi: 10.1055/s-0040-1715456Di Minno A, Ambrosino P, Calcaterra I, Di Minno MND. COVID-19 and venous thromboembolism: A meta-analysis of literature studies. Semin Thromb Hemost. 2020;46(7):763-771. doi: 10.1055/s-0040-1715456Zuin M, Rigatelli G, Zuliani G, Roncon L. The risk of thrombosis after acute-COVID-19 infection. QJM. 2021;15:hcab054. doi: 10.1093/qjmed/hcab054Zuin M, Rigatelli G, Zuliani G, Roncon L. The risk of thrombosis after acute-COVID-19 infection. QJM. 2021;15:hcab054. doi: 10.1093/qjmed/hcab054Higgins V, Sohaei D, Diamandis EP, Prassas I. COVID-19: from an acute to chronic disease? Potential long-term health consequences. Crit Rev Clin Lab Sci. 2020;21:1-23. doi: 10.1080/10408363.2020.1860895Higgins V, Sohaei D, Diamandis EP, Prassas I. COVID-19: from an acute to chronic disease? Potential long-term health consequences. Crit Rev Clin Lab Sci. 2020;21:1-23. doi: 10.1080/10408363.2020.1860895Amann K, Boor P, Wiech T, Singh J, Vonbrunn E, Knöll A, et al. COVID-19 effects on the kidney. Pathologe. 2021;1:1-5. doi: 10.1007/s00292-020-00900-xAmann K, Boor P, Wiech T, Singh J, Vonbrunn E, Knöll A, et al. COVID-19 effects on the kidney. Pathologe. 2021;1:1-5. doi: 10.1007/s00292-020-00900-xAskari H, Sanadgol N, Azarnezhad A, Tajbakhsh A, Rafiei H, Safarpour AR, et al. Kidney diseases and COVID-19 infection: causes and effect, supportive therapeutics and nutritional perspectives. Heliyon. 2021;7(1):e06008. doi: 10.1016/j.heliyon.2021.e06008Askari H, Sanadgol N, Azarnezhad A, Tajbakhsh A, Rafiei H, Safarpour AR, et al. Kidney diseases and COVID-19 infection: causes and effect, supportive therapeutics and nutritional perspectives. Heliyon. 2021;7(1):e06008. doi: 10.1016/j.heliyon.2021.e06008Lahiri D, Ardila A. COVID-19 pandemic: A neurological perspective. Cureus. 2020;29;12(4):e7889. doi: 10.7759/cureus.7889Lahiri D, Ardila A. COVID-19 pandemic: A neurological perspective. Cureus. 2020;29;12(4):e7889. doi: 10.7759/cureus.7889Javed A. Neurological associations of SARS-CoV-2 infection: A systematic review. CNS Neurol Disord Drug Targets. 2021;16. doi: 10.2174/1871527320666210216121211Javed A. Neurological associations of SARS-CoV-2 infection: A systematic review. CNS Neurol Disord Drug Targets. 2021;16. doi: 10.2174/1871527320666210216121211Bandeira IP, Schlindwein MAM, Breis LC, Peron JPS, Gonçalves MVM. Neurological complications of the COVID-19 pandemic: What have we got so far? Adv Exp Med Biol. 2021;1321:21-31. doi: 10.1007/978-3-030-59261-5_2Bandeira IP, Schlindwein MAM, Breis LC, Peron JPS, Gonçalves MVM. Neurological complications of the COVID-19 pandemic: What have we got so far? Adv Exp Med Biol. 2021;1321:21-31. doi: 10.1007/978-3-030-59261-5_2Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, FusarPoli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: A systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7(7):611-627. doi: 10.1016/S2215-0366(20)30203-0Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, FusarPoli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: A systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7(7):611-627. doi: 10.1016/S2215-0366(20)30203-0Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, et al. Autonomic dysfunction in ‘long COVID’: Rationale, physiology and management strategies. Clin Med (Lond). 2021;21(1):e63-e67. doi: 10.7861/clinmed.2020-0896Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, et al. Autonomic dysfunction in ‘long COVID’: Rationale, physiology and management strategies. Clin Med (Lond). 2021;21(1):e63-e67. doi: 10.7861/clinmed.2020-0896Østergaard L. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol Rep. 2021;9(3):e14726. doi: 10.14814/phy2.14726Østergaard L. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol Rep. 2021;9(3):e14726. doi: 10.14814/phy2.14726De Giorgio MR, Di Noia S, Morciano C, Conte D. The impact of SARS-CoV-2 on skeletal muscles. Acta Myol. 2020;1;39(4):307-312. doi: 10.36185/2532-1900-034De Giorgio MR, Di Noia S, Morciano C, Conte D. The impact of SARS-CoV-2 on skeletal muscles. Acta Myol. 2020;1;39(4):307-312. doi: 10.36185/2532-1900-034Somasundaram NP, Ranathunga I, Ratnasamy V, Wijewickrama PSA, Dissanayake HA, Yogendranathan N, et al. The impact of SARS-CoV-2 virus infection on the endocrine system. J Endocr Soc. 2020;2;4(8):bvaa082. doi: 10.1210/jendso/bvaa082Somasundaram NP, Ranathunga I, Ratnasamy V, Wijewickrama PSA, Dissanayake HA, Yogendranathan N, et al. The impact of SARS-CoV-2 virus infection on the endocrine system. J Endocr Soc. 2020;2;4(8):bvaa082. doi: 10.1210/jendso/bvaa082Ehrenfeld M, Tincani A, Andreoli L, Cattalini M, Greenbaum A, Kanduc D, et al. Covid-19 and autoimmunity. Autoimmun Rev. 2020;19(8):102597. doi: 10.1016/j.autrev.2020.102597Ehrenfeld M, Tincani A, Andreoli L, Cattalini M, Greenbaum A, Kanduc D, et al. Covid-19 and autoimmunity. Autoimmun Rev. 2020;19(8):102597. doi: 10.1016/j.autrev.2020.102597Dotan A, Muller S, Kanduc D, David P, Halpert G, Shoenfeld Y. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun Rev. 2021;19:102792. doi: 10.1016/j.autrev.2021.102792Dotan A, Muller S, Kanduc D, David P, Halpert G, Shoenfeld Y. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun Rev. 2021;19:102792. doi: 10.1016/j.autrev.2021.102792Weng LM, Su X, Wang XQ. Pain symptoms in patients with coronavirus disease (COVID-19): A literature review. J Pain Res. 2021;26;14:147-159. doi: 10.2147/JPR.S269206Weng LM, Su X, Wang XQ. Pain symptoms in patients with coronavirus disease (COVID-19): A literature review. J Pain Res. 2021;26;14:147-159. doi: 10.2147/JPR.S269206Walitt B, Bartrum E. A clinical primer for the expected and potential post-COVID-19 syndromes. Pain Rep. 2021;16;6(1):e887. doi: 10.1097/PR9.0000000000000887Walitt B, Bartrum E. A clinical primer for the expected and potential post-COVID-19 syndromes. Pain Rep. 2021;16;6(1):e887. doi: 10.1097/PR9.0000000000000887Marinangeli F, Giarratano A, Petrini F. Chronic pain and COVID-19: Pathophysiological, clinical and organizational issues. Minerva Anestesiol. 2020. doi: 10.23736/S0375-9393.20.15029-6Marinangeli F, Giarratano A, Petrini F. Chronic pain and COVID-19: Pathophysiological, clinical and organizational issues. Minerva Anestesiol. 2020. doi: 10.23736/S0375-9393.20.15029-6Kemp Н, Corner Е, Colvin L. Chronic pain after COVID-19: Implications for rehabilitation. Br J Anaesth. 2020;125(4):436-440. doi: 10.1016/j.bja.2020.05.021Kemp Н, Corner Е, Colvin L. Chronic pain after COVID-19: Implications for rehabilitation. Br J Anaesth. 2020;125(4):436-440. doi: 10.1016/j.bja.2020.05.021Galal I, Mohamed Hussein A, Amin M, Saad MM, Zayan HEE, Abdelsayed MZ, et al. Determinants of persistent post-COVID-19 symptoms: Value of a novel COVID-19 symptom score. The Egyptian Journal of Bronchology. 2021;15:10. doi: 10.1186/s43168-020-00049-4Galal I, Mohamed Hussein A, Amin M, Saad MM, Zayan HEE, Abdelsayed MZ, et al. Determinants of persistent post-COVID-19 symptoms: Value of a novel COVID-19 symptom score. The Egyptian Journal of Bronchology. 2021;15:10. doi: 10.1186/s43168-020-00049-4Carfì A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;11;324(6):603-605. doi: 10.1001/jama.2020.12603Carfì A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;11;324(6):603-605. doi: 10.1001/jama.2020.12603Halpin S, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2021;93(2):1013-1022. doi: 10.1002/jmv.26368Halpin S, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2021;93(2):1013-1022. doi: 10.1002/jmv.26368Jacobs L, Paleoudis E, Bari D, Nyirenda T, Friedman T, Gupta A, et al. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS One. 2020;11;15(12):e0243882. doi: 10.1371/journal.pone.0243882Jacobs L, Paleoudis E, Bari D, Nyirenda T, Friedman T, Gupta A, et al. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS One. 2020;11;15(12):e0243882. doi: 10.1371/journal.pone.0243882Meyer-Frießem CH, Gierthmühlen J, Baron R, Sommer C, Üçeyler N, Enax-Krumova EK. Pain during and after COVID-19 in Germany and worldwide: A narrative review of current knowledge. Pain Rep. 2021;20;6(1):e893. doi: 10.1097/PR9.0000000000000893Meyer-Frießem CH, Gierthmühlen J, Baron R, Sommer C, Üçeyler N, Enax-Krumova EK. Pain during and after COVID-19 in Germany and worldwide: A narrative review of current knowledge. Pain Rep. 2021;20;6(1):e893. doi: 10.1097/PR9.0000000000000893Soares FHC, Kubota GT, Fernandes AM, Hojo B, Couras C, Costa BV, et al. Prevalence and characteristics of new-onset pain in COVID-19 survivors, a controlled study. Eur J Pain. 2021. doi: 10.1002/ejp.1755Soares FHC, Kubota GT, Fernandes AM, Hojo B, Couras C, Costa BV, et al. Prevalence and characteristics of new-onset pain in COVID-19 survivors, a controlled study. Eur J Pain. 2021. doi: 10.1002/ejp.1755Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397(10270):220-232. doi: 10.1016/S0140-6736(20)32656-8Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397(10270):220-232. doi: 10.1016/S0140-6736(20)32656-8Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo P, Cuapio A, et al. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Res Sq. 2021:rs.3.rs-266574. doi: 10.21203/rs.3.rs-266574/v1Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo P, Cuapio A, et al. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Res Sq. 2021:rs.3.rs-266574. doi: 10.21203/rs.3.rs-266574/v1Himmels JPW, Qureshi SA, Brurberg KG, Gravningen KM. COVID-19: Long-term effects of COVID-19. Rapid review. URL: https://www.fhi.no/en/publ/2021/Long-Term-Effects-ofCOVID-19 (Accessed: 18th April 2021).Himmels JPW, Qureshi SA, Brurberg KG, Gravningen KM. COVID-19: Long-term effects of COVID-19. Rapid review. URL: https://www.fhi.no/en/publ/2021/Long-Term-Effects-ofCOVID-19 (Accessed: 18th April 2021).Attal N, Martinez V, Bouhassira D. Potential for increased prevalence of neuropathic pain after the COVID-19 pandemic. Pain Rep. 2021;6(1):e884. doi: 10.1097/PR9.0000000000000884Attal N, Martinez V, Bouhassira D. Potential for increased prevalence of neuropathic pain after the COVID-19 pandemic. Pain Rep. 2021;6(1):e884. doi: 10.1097/PR9.0000000000000884Mohabbat AB, Mohabbat NML, Wight EC. Fibromyalgia and chronic fatigue syndrome in the age of COVID-19. Mayo Clin Proc Innov Qual Outcomes. 2020;4(6):764-766. doi: 10.1016/j.mayocpiqo.2020.08.002Mohabbat AB, Mohabbat NML, Wight EC. Fibromyalgia and chronic fatigue syndrome in the age of COVID-19. Mayo Clin Proc Innov Qual Outcomes. 2020;4(6):764-766. doi: 10.1016/j.mayocpiqo.2020.08.002Komaroff AL, Bateman L. Will COVID-19 lead to myalgic encephalomyelitis/chronic fatigue syndrome? Front Med (Lausanne). 2021;7:606824. doi: 10.3389/fmed.2020.606824Komaroff AL, Bateman L. Will COVID-19 lead to myalgic encephalomyelitis/chronic fatigue syndrome? Front Med (Lausanne). 2021;7:606824. doi: 10.3389/fmed.2020.606824Wostyn P. COVID-19 and chronic fatigue syndrome: Is the worst yet to come? Med Hypotheses. 2021;146:110469. doi: 10.1016/j.mehy.2020.110469Wostyn P. COVID-19 and chronic fatigue syndrome: Is the worst yet to come? Med Hypotheses. 2021;146:110469. doi: 10.1016/j.mehy.2020.110469Li Y, Scherer N, Felix L, Kuper H. Prevalence of depression, anxiety and post-traumatic stress disorder in health care workers during the COVID-19 pandemic: A systematic review and meta-analysis. PLoS One. 2021;16(3):e0246454. doi: 10.1371/journal.pone.0246454Li Y, Scherer N, Felix L, Kuper H. Prevalence of depression, anxiety and post-traumatic stress disorder in health care workers during the COVID-19 pandemic: A systematic review and meta-analysis. PLoS One. 2021;16(3):e0246454. doi: 10.1371/journal.pone.0246454Parisi S, Borrelli R, Bianchi S, Fusaro E. Viral arthritis and COVID-19. Lancet Rheumatol. 2020;2(11):e655-e657. doi: 10.1016/S2665-9913(20)30348-9Parisi S, Borrelli R, Bianchi S, Fusaro E. Viral arthritis and COVID-19. Lancet Rheumatol. 2020;2(11):e655-e657. doi: 10.1016/S2665-9913(20)30348-9Gasparotto M, Framba V, Piovella C, Doria A, Iaccarino L. PostCOVID-19 arthritis: A case report and literature review. Clin Rheumatol. 2021:1-6. doi: 10.1007/s10067-020-05550-1Gasparotto M, Framba V, Piovella C, Doria A, Iaccarino L. PostCOVID-19 arthritis: A case report and literature review. Clin Rheumatol. 2021:1-6. doi: 10.1007/s10067-020-05550-1Nalbandian A, Sehgal K, Gupta A. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601-615. doi: 10.1038/s41591-021-01283-zNalbandian A, Sehgal K, Gupta A. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601-615. doi: 10.1038/s41591-021-01283-zChandrashekara S, Jaladhar P, Paramshetti S, Ramachandran V, Nizar SF, Kori D. Post COVID inflammation syndrome: Different manifestations caused by the virus. J Assoc Physicians India. 2020;68(12):33-34.Chandrashekara S, Jaladhar P, Paramshetti S, Ramachandran V, Nizar SF, Kori D. Post COVID inflammation syndrome: Different manifestations caused by the virus. J Assoc Physicians India. 2020;68(12):33-34.Wong AY, MacKenna B, Morton CE, Schultze A, Walker AJ, Bhaskaran K, et al. Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: An OpenSAFELY cohort analysis based on two cohorts. Ann Rheum Dis. 2021 Jan 21. doi: 10.1136/annrheumdis-2020-219517Wong AY, MacKenna B, Morton CE, Schultze A, Walker AJ, Bhaskaran K, et al. Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: An OpenSAFELY cohort analysis based on two cohorts. Ann Rheum Dis. 2021 Jan 21. doi: 10.1136/annrheumdis-2020-219517Demeco A, Marotta N, Barletta M, Pino I, Marinaro C, Petraroli A, et al. Rehabilitation of patients post-COVID-19 infection: A literature review. J Int Med Res. 2020;48(8):300060520948382. doi: 10.1177/0300060520948382Demeco A, Marotta N, Barletta M, Pino I, Marinaro C, Petraroli A, et al. Rehabilitation of patients post-COVID-19 infection: A literature review. J Int Med Res. 2020;48(8):300060520948382. doi: 10.1177/0300060520948382Candan SA, Elibol N, Abdullahi A. Consideration of prevention and management of long-term consequences of post-acute respiratory distress syndrome in patients with COVID-19. Physiother Theory Pract. 2020;36(6):663-668. doi: 10.1080/09593985.2020.1766181Candan SA, Elibol N, Abdullahi A. Consideration of prevention and management of long-term consequences of post-acute respiratory distress syndrome in patients with COVID-19. Physiother Theory Pract. 2020;36(6):663-668. doi: 10.1080/09593985.2020.1766181Yang YC, Chou CL, Kao CL. Exercise, nutrition, and medication considerations in the light of the COVID pandemic, with specific focus on geriatric population: A literature review. J Chin Med Assoc. 2020;83(11):977-980. doi: 10.1097/JCMA.0000000000000393Yang YC, Chou CL, Kao CL. Exercise, nutrition, and medication considerations in the light of the COVID pandemic, with specific focus on geriatric population: A literature review. J Chin Med Assoc. 2020;83(11):977-980. doi: 10.1097/JCMA.0000000000000393

The authors declare that there are no conflicts of interest present.